• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CTI settles with GE

Article

Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to

Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to prevent these former GE employees from potentially disclosing or using GE confidential information. The staff had left GE and joined CTI or PETNET before the litigation was initiated. CTI Molecular Imaging announced that the parties worked together to ensure that sufficient safeguards were in place to prevent potential disclosure of GE confidential information and further disputes. CTI Molecular Imaging will incur no charges in connection with the settlement.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.